Jeffrey J Miceli

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder
    Jeffrey J Miceli
    Pfizer Global Research and Development, New London, Connecticut 06320, USA
    Clin Ther 32:472-91. 2010
  2. ncbi Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder
    Jeffrey J Miceli
    Pfizer Global Research and Development, New London, Connecticut, USA
    Pharmacotherapy 30:127-35. 2010
  3. ncbi Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers
    Jeffrey J Miceli
    Pfizer Global Research and Development, Groton, CT, USA
    J Clin Pharmacol 45:620-30. 2005
  4. ncbi A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
    Edmund P Harrigan
    Pfizer Global Research and Development, New London, CT 06320, USA
    J Clin Psychopharmacol 24:62-9. 2004

Collaborators

Detail Information

Publications4

  1. ncbi Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder
    Jeffrey J Miceli
    Pfizer Global Research and Development, New London, Connecticut 06320, USA
    Clin Ther 32:472-91. 2010
    ..Antipsychotic agents have been associated with a prolonged QT interval. Data on the effects of ziprasidone and haloperidol on the QTc interval are lacking...
  2. ncbi Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder
    Jeffrey J Miceli
    Pfizer Global Research and Development, New London, Connecticut, USA
    Pharmacotherapy 30:127-35. 2010
    ..To characterize the effect of oral ziprasidone and haloperidol on the corrected QT (QTc) interval under steady-state conditions. Design. Prospective, randomized, open-label, parallel-group study...
  3. ncbi Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers
    Jeffrey J Miceli
    Pfizer Global Research and Development, Groton, CT, USA
    J Clin Pharmacol 45:620-30. 2005
    ..No significant effects on renal function or other laboratory values were noted. These results support the use of IM ziprasidone in treating acutely agitated patients with schizophrenia...
  4. ncbi A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
    Edmund P Harrigan
    Pfizer Global Research and Development, New London, CT 06320, USA
    J Clin Psychopharmacol 24:62-9. 2004
    ..The theoretical risk of cardiotoxicity associated with QTc prolongation should be balanced against the substantial clinical benefits associated with atypical antipsychotics and the likelihood of other toxicities...